ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novel COVID-19 vaccine shows promise in Canadian trial
July 05, 2021Phase I data shows VBI-2902a induced neutralisation and antibody titres up to five times that of people who had recovered from COVID-19 infection. -
CEPI and VBI to develop vaccines against SARS-CoV-2 variants
March 12, 2021The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants. -
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints
January 14, 2020VBI Vaccines has reported top-line data from CONSTANT, the second pivotal Phase 3 study, assessing lot-to-lot manufacturing consistency of Sci-B-Vac, the company’s trivalent hepatitis B (HBV) vaccine ... -
News of Note—VBI Vaccines, BiondVax and more
September 06, 2017VBI Vaccines won FDA approval for its phase 3 program of hep B shot Sci-B-Vac. Enrollment is expected to start this year in the U.S., Europe and Canada. The vaccine is already licensed in Israel and 14 other countries. Release -
News of Note—Seqirus, VBI and Altimmune
August 23, 2017Approval of Fluad in the U.K. is among this week's news of note.
Pharma Sources Insight January 2025
